Good Morning America coanchor Robin Roberts returned to work on Monday, a little more than one week after her breast cancer surgery. Some think her return was a bit hasty. Some think it was the absolute right thing to do. I'm of this camp -- the jump-back-into-life approach. It's exactly what I did after my surgery and throughout every step of my treatment. And while there were surely days I could have cut myself some slack, I tried to keep on my toes. It was the only way I knew how to manage the chaos of cancer.

In the spirit of helping women cope with their breast cancer diagnoses, Roberts' very own doctor offers some insightful words of wisdom. Click here for guidance about returning to work, managing through surgery and radiation, maintaining emotional health, and the importance of mammograms and self-exams.

What is your take on how Roberts is handling cancer and how her doctor is handling the topics that become critical in the fight against this disease?

After several weeks of hiding and down time, a few weeks ago I made an official announcement to the non profit organization that I founded Indie Music For Life and its two entities Laughs For Life and Indiegrrl. I dropped off of this blog page for a month and am ready to write again. I needed a break. A break to sort through things. To sort through life.

When you or a loved one are diagnosed with cancer it changes your life. Finding out you have cancer takes your breath away and from that point your breath is the most valuable thing to you in your life. Breath and time. Nothing is normal any more. Not your dreams, your nightmares, and not your waking moments.

A personal diagnosis of chronic myloid leukemia in February sent me into a whirlwind of emotions. At that point, all the fear, terror, and stomach knots from my past rounds of cancer came back. Nobody free of cancer could ever appreciate how utterly devastating the news of contracting it could be and the news that it has returned is even more devastating because you know what uphill climbs you must make again. Once you have been diagnosed with cancer you always look over your shoulder for the beast to return. He has caught up with me several times now and so I am speeding up in my race trying to see who is the best long distance runner. Every ache you feel or every little un-ordinary thing that happens with your body sends you into " What If " mode. It is extremely hard living in that mode of thinking but you can't avoid it.

My past struggles with cancer were very private. But then I was not the head of a non profit organization that raises money for cancer research and educational awareness on the powers of music and laughter as therapy for cancer patients. I wasn't the head of the largest networking group of female songwriters known as Indiegrrl that has since become a part of Indie Music for Life. Laughs For Life had not even been thought of yet and now with the direction and help of good friend and comedian Shelly Ryan it is now a reality. I hadn't even started my music career. Having cancer is what lead me to pursue my career in music and chase my dreams. It wasn't until I started working on my CDs that my cancer became really public other than with my close friends and family and then working to set up the Indie Music For Life non profit put it out there even more.

Cancer drug Gleevec, used for the treatment of chronic myeloid leukemia (CML), has been pulled out of another round of testing so it can get to work stopping the return of a rare stomach cancer. It's that good, according to findings announced on Thursday.

The promise of Gleevec should make it standard treatment for people with gastrointestinal stromal tumors (GIST), a stomach and intestine cancer diagnosed in 5,000 to 6,000 Americans each year.

The drug has already been used for patients whose disease is too advanced for surgery. Now it will be used for those whose tumors can be removed. The drug will be administered for at least one year post-surgery.

More than 600 people participated in this Gleevec trial. Each person took either Gleevec or a sugar pill for one year after surgery. After the one-year mark, cancer returned in 17 percent of people taking the sugar pill and in 3 percent of people taking the actual drug.

Since 50 to 90 percent of GIST cases recur over time, this is great news, say researchers who call Gleevec a highly targeted cancer drug with few side effects.

Women with early stage breast cancer now have a new tool at their disposal. The tool -- called MammaPrint -- is newly approved by the FDA and while it is not yet a perfect measure, it can be used along with other information to estimate whether breast cancer is likely to return in five or 10 years.

The value of this test, that measures through computer analysis the activity of 70 genes using a sample of tissue removed from a breast tumor, is that doctors and patients can better determine course of treatments.

MammoPrint offers two results -- high risk and low risk -- and accurately picked in studies which women were at low risk at least 90 percent of the time. However, for women who were told they were at high risk for recurrence as a result of the test, just 23 percent experienced a relapse.

"You can't go all the way to the bank with this test," says FDA official Dr. Steven Gutman who argues the test is still better than having no information at all.

Agendia, the Dutch maker of MammoPrint, is exploring ways to make this one-of-a-kind product available in the United States. It has been used in the Netherlands since 2005.

"This test has enormous implications for the short-term future of cancer research in general, and is one of the truly great breakthroughs of our time," says Cancer Blog reader Gregory Pawelski with whom I am grateful for sharing this story tip with me.

Pancreatic cancer is one of the deadliest forms of cancer. So any bit of progress on the pancreatic cancer front is a big deal. And researchers are happy to report they've found a chemotherapy drug that can help patients who have received surgery prevent a return of the disease for a longer period of time.

In a German study, participants who received Gemzar, or gemcitabine, lived an average of 13.4 months without their cancers coming back. Participants who did not receive the drug lived without the disease for 6.9 months. While the findings of this study may seem modest, they really are quite encouraging because pancreatic cancer is such a rapid killer, and patients with this disease have the worst chances of recovery.

This study, published in Wednesday's Journal of the American Medical Association, brings hope for the mere 20 percent of pancreatic cancer patients who are candidates for surgery. While surgery is the best hope for a cure, the disease still returns in the majority of cases -- so Gemzar is surely worth a shot.

It should be noted that some study authors report financial ties to Gemzar drugmaker Eli Lilly and Co. Researchers, however, report the firm had no influence in design or data interpretation.

The evidence is stacking up. And it seems almost everyone will soon agree that exercising can help prevent a return of cancer for those who have already done battle with the disease.

The American Cancer Society just issued a report updating nutrition and physical activity recommendations for cancer survivors. Exercise tops the list of recommendations.

For some types of cancers, exercising for just one to three hours per week can lower the risk of cancer recurrence and death, as well as death from all causes. Exercise has also been shown to improve fitness, diminish fatigue, and boost quality of life for survivors.

The report also states that while a vegetarian diet may be healthful in some ways, there is no direct proof that the diet can prevent cancer recurrence. Survivors who do choose a vegetarian lifestyle should ensure they are receiving an adequate intake of nutrients.

A standard multivitamin and mineral supplement equivalent to 100 percent of the Daily Value can help survivors meet their nutrient needs when it's difficult to eat a healthy diet. Some supplements -- such as those high in folic acid or antioxidants -- may be harmful during cancer treatment.

According to the American Cancer Society, food safety is especially important for cancer survivors, especially during treatment that causes immunosuppression.

And then there's alcohol. Alcohol can affect the risk for new primary cancers and should be used sparingly -- or not at all.

If we made no further progress in breast cancer research from this day on, the number of women dying from breast cancer five years from now would still drop substantially because we've progressed so much over the past few years, says MD Eric Winer in the October 2006 issue of Oprah magazine. Winer, director of the Breast Oncology Center at Dana-Farber Cancer Institute and associate professor of medicine at Harvard Medical School, is right. There has been a lot of progress. Breast cancer research is on a roll. And here are seven reasons why.

I was examined yesterday by my radiation oncologist and two medical students during a six-month follow-up appointment. And any apprehension I had prior to the visit -- about a recurrence of breast cancer or the detection of cancer somewhere else in my body -- is gone. Because I walked away with the news that I am doing just fine. No lumps or bumps or suspicious masses were found. No enlarged lymph nodes were detected. And since I did not report any pain or tenderness or sensitivity or other trouble, I was sent on my way with nothing more than a notice for a return appointment in another six months. I have other appointments hanging in the balance -- one with my medical oncologist in August and a mammogram in November -- and I am sure hesitation and worry will again sneak into my head. But for now, I can only feel the true exhilaration that comes from truly good news. Like the exhilaration that comes from a breathtaking moment at the ocean -- where the power and beauty of the sea and the sky and the sand is all it takes for one five-year-old boy to feel amazingly free.

As if the horrors of breast cancer are not enough -- surgery and recovery, chemotherapy and recovery, radiation and recovery, additional treatments and recovery -- weight gain often comes along and rounds out the full breast cancer package. It is most common for women who have chemotherapy -- the curse is not often seen for women who have surgery alone or surgery followed by radiation -- and while it may seem the lesser of all evils for some women, others may be plagued by an additional battle with weight. In addition to the self esteem blow that breast cancer delivers -- complete with scars and removal of breasts and reconstruction and hair loss -- weight gain in this body-image obsessed era can take its toll. There are also health concerns related to weight gain -- and an excess of weight is reported to sometimes influence a return of breast cancer and can be a risk factor for other cancers too.

The American Cancer Society reports that the average weight gain is five to eight pounds over a year's time -- but that gaining 25 pounds is not uncommon either. This phenomenon is somewhat of a mystery, although there are some theories about why women are at risk for this not-so-pleasant side effect of breast cancer. Some women get nauseated during chemotherapy and don't eat much -- but others have intense food cravings and tend to eat more. Body composition may also change and research shows that chemotherapy possibly diminishes lean body mass and increases fatty tissue. Menopause may also be to blame -- natural and chemically-induced menopause operate the same and both slow metabolism. So it takes more physical activity to burn what less activity accomplished prior to chemotherapy. Women experiencing treatment also tend to exercise less which can contribute to weight gain. And some women fault the Tamoxifen they take following chemotherapy -- although research does not support a strong link between the two. There are many possibilities. Yet none of them are definite. There is one definite, though -- a healthy menu, a healthy exercise routine, and a healthy support team can help women ward off this unfair consequence of an unfair disease.